Stryker
Stryker Corporation, commonly referred to as Stryker, is a leading global medical technology company headquartered in the United States. Founded in 1941, Stryker has established itself as a key player in the orthopaedics, surgical equipment, and neurotechnology sectors, with significant operations across North America, Europe, and Asia-Pacific. The company is renowned for its innovative products, including advanced surgical instruments, implantable devices, and patient handling solutions, which are designed to enhance surgical outcomes and improve patient care. Stryker's commitment to quality and innovation has positioned it as a trusted partner in the healthcare industry, earning numerous accolades for its contributions to medical technology. With a strong market presence, Stryker continues to lead the way in developing cutting-edge solutions that address the evolving needs of healthcare professionals and patients alike.
DitchCarbon Score
How does Stryker's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Stryker's score of 24 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Stryker's reported carbon emissions
In 2022, Stryker reported total carbon emissions of approximately 243,317,000 kg CO2e in the UK, with significant contributions from Scope 1 and Scope 2 emissions. Specifically, Scope 1 emissions accounted for about 57,383,000 kg CO2e, while Scope 2 emissions totalled approximately 117,059,000 kg CO2e. The company also reported Scope 3 emissions, primarily from business travel, which amounted to about 68,875,000 kg CO2e. In the previous year, 2021, Stryker's global emissions were approximately 173,457,000 kg CO2e for Scope 1 and 2 combined, indicating a slight decrease in emissions over the years. The company has not publicly disclosed specific reduction targets or initiatives as part of its climate commitments, which suggests a need for further transparency in its sustainability strategy. Overall, Stryker's emissions data highlights the importance of addressing both direct and indirect emissions as part of its climate strategy, particularly in the context of the medical technology industry, which is increasingly focused on sustainability and reducing its carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 25,284,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 146,705,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 2,321,951,000 | - | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Stryker is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
